Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Noctiva™ (desmopressin acetate) – New drug approval
March 3, 2017 – The FDA announced the approval of Serenity Pharmaceutical’s Noctiva (desmopressin acetate), for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void.
